메뉴 건너뛰기




Volumn 8, Issue , 2008, Pages

The Procalcitonin And Survival Study (PASS) - A Randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients

(29)  Jensen, Jens Ulrik a,b,c   Lundgren, Bettina a   Hein, Lars d   Mohr, Thomas d,e   Petersen, Pernille L d   Andersen, Lasse H d   Lauritsen, Anne Ø d   Hougaard, Sine d   Mantoni, Teit d   Bømler, Bonnie d   Thornberg, Klaus J e   Thormar, Katrin e   Løken, Jesper a   Steensen, Morten a   Carl, Peder a   Petersen, John Asger a   Tousi, Hamid e   Søe Jensen, Peter e   Bestle, Morten f   Hestad, Søren f   more..


Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM; GLYCOPEPTIDE; NITROIMIDAZOLE DERIVATIVE; OXAZOLIDINONE DERIVATIVE; PROCALCITONIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

EID: 48749124099     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-8-91     Document Type: Article
Times cited : (35)

References (10)
  • 1
    • 0347122086 scopus 로고    scopus 로고
    • Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis
    • 14668610 10.1097/01.CCM.0000098031.24329.10
    • Garnacho-Montero J Garcia-Garmendia JL Barrero-Almodovar A Jimenez-Jimenez FJ Perez-Paredes C Ortiz-Leyba C Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis Crit Care Med 2003, 31(12):2742-51. 14668610 10.1097/01.CCM.0000098031.24329.10
    • (2003) Crit Care Med , vol.31 , Issue.12 , pp. 2742-2751
    • Garnacho-Montero, J.1    Garcia-Garmendia, J.L.2    Barrero-Almodovar, A.3    Jimenez-Jimenez, F.J.4    Perez-Paredes, C.5    Ortiz-Leyba, C.6
  • 3
  • 8
    • 33748782250 scopus 로고    scopus 로고
    • Procalcitonin increase in early identification of crittically ill patients at high risk of mortality
    • 10.1097/01.CCM.0000239116.01855.61
    • Jensen JU Heslet L Jensen TH Espersen K Steffensen P Tvede M Procalcitonin increase in early identification of crittically ill patients at high risk of mortality Crit Care Med 2006, 34:10. 10.1097/ 01.CCM.0000239116.01855.61
    • (2006) Crit Care Med , vol.34 , pp. 10
    • Jensen, J.U.1    Heslet, L.2    Jensen, T.H.3    Espersen, K.4    Steffensen, P.5    Tvede, M.6
  • 10
    • 1342265610 scopus 로고    scopus 로고
    • Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: Cluster-randomised, single-blinded intervention trial
    • 14987884 10.1016/S0140-6736(04)15591-8
    • Christ-Crain M Jaccard-Stolz D Bingisser R Gencay MM Huber PR Tamm M Muller B Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: Cluster-randomised, single-blinded intervention trial Lancet 2004, 363(9409):600-7. 14987884 10.1016/S0140-6736(04)15591-8
    • (2004) Lancet , vol.363 , Issue.9409 , pp. 600-607
    • Christ-Crain, M.1    Jaccard-Stolz, D.2    Bingisser, R.3    Gencay, M.M.4    Huber, P.R.5    Tamm, M.6    Muller, B.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.